Bristol-Myers Squibb sell Morgan Stanley
Start price
10.07.25
/
50%
€41.13
Target price
10.07.26
€28.95
Performance (%)
8.92%
Price
05.12.25
€44.80
Summary
This prediction is currently active. With a performance of 8.92%, the SELL prediction by Morgan_Stanley for Bristol-Myers Squibb is trending in the wrong direction This prediction currently runs until 10.07.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 5.735% | 5.735% |
| iShares Core DAX® | 0.760% | -0.301% |
| iShares Nasdaq 100 | 0.732% | -1.001% |
| iShares Nikkei 225® | 1.025% | -3.621% |
| iShares S&P 500 | -0.036% | -0.194% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb Company (NYSE: BMY) had its price target lowered by analysts at Morgan Stanley from $36.00 to $34.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€56.01
12.11.24
12.11.24
€36.70
12.11.25
12.11.25
-23.83%
13.11.25
13.11.25
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€49.80
27.10.23
27.10.23
€47.31
27.10.24
27.10.24
-3.66%
28.10.24
28.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-11.04%
12.10.24
12.10.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.70
19.07.23
19.07.23
€52.70
19.07.24
19.07.24
-30.56%
20.07.24
20.07.24